Bausch Health Companies Inc. Income Taxes Paid
Bausch Health Companies Inc. (BHC) reported Income Taxes Paid of $163.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-02-19
- Bausch Health Companies Inc. income taxes paid for fiscal 2025 was $163.00M, a 167.21% increase from fiscal 2024.
- Bausch Health Companies Inc. income taxes paid for fiscal 2024 was $61.00M, a 74.26% decline from fiscal 2023.
- Bausch Health Companies Inc. income taxes paid for fiscal 2023 was $237.00M, a 10.90% decline from fiscal 2022.
- Bausch Health Companies Inc. income taxes paid for fiscal 2022 was $266.00M, a 10.83% increase from fiscal 2021.
| Period end | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|
| 2025-12-31 | $163.00M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $61.00M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $237.00M 10-K · filed 2026-02-19 | |
| 2022-12-31 | $266.00M 10-K · filed 2025-02-20 | |
| 2021-12-31 | $240.00M 10-K · filed 2024-02-22 | |
| 2020-12-31 | $162.00M 10-K · filed 2023-02-23 | |
| 2019-12-31 | $172.00M 8-K · filed 2022-05-11 | |
| 2018-12-31 | $138.00M 8-K · filed 2021-05-04 | |
| 2017-12-31 | $179.00M 10-K · filed 2020-02-19 | |
| 2016-12-31 | $149.00M 10-K · filed 2019-02-20 | |
| 2015-12-31 | $95.00M 8-K · filed 2018-08-10 | $94.60M 10-K · filed 2016-04-29 |
| 2014-12-31 | $99.00M 10-K · filed 2017-03-01 | $98.70M 10-K · filed 2015-02-25 |
| 2013-12-31 | $65.10M 10-K · filed 2016-04-29 | $65.07M 10-K · filed 2014-02-28 |
| 2012-12-31 | $41.40M 10-K · filed 2015-02-25 | $41.42M 10-K · filed 2013-02-28 |
| 2011-12-31 | $45.40M 10-K · filed 2014-02-28 | |
| 2010-12-31 | $26.30M 10-K · filed 2013-02-28 | |
| 2009-12-31 | $12.14M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |